Skip to main content
. 2020 Nov 24;4(22):5863–5867. doi: 10.1182/bloodadvances.2020002537

Table 3.

Clinical strategies in lymphoma to overcome immune suppression

Strategies
• Target immune checkpoints to prevent immune suppression
• Promote tumor cell phagocytosis and antigen presentation by engaging macrophages
• Improve malignant cell engagement using CARs
• Activate T cells and NK cells using bispecific antibodies